451 related articles for article (PubMed ID: 21861235)
1. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.
Li X; Wang J; Zhang X; Zeng Y; Liang L; Ding Y
Ann Surg Oncol; 2012 Jan; 19(1):145-53. PubMed ID: 21861235
[TBL] [Abstract][Full Text] [Related]
2. The significance of PITX2 overexpression in human colorectal cancer.
Hirose H; Ishii H; Mimori K; Tanaka F; Takemasa I; Mizushima T; Ikeda M; Yamamoto H; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2011 Oct; 18(10):3005-12. PubMed ID: 21479692
[TBL] [Abstract][Full Text] [Related]
3. Notch2 expression is decreased in colorectal cancer and related to tumor differentiation status.
Chu D; Zheng J; Wang W; Zhao Q; Li Y; Li J; Xie H; Zhang H; Dong G; Xu C; Li M; Chen D; Ji G
Ann Surg Oncol; 2009 Dec; 16(12):3259-66. PubMed ID: 19653042
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
[TBL] [Abstract][Full Text] [Related]
5. GATA6 predicts prognosis and hepatic metastasis of colorectal cancer.
Shen F; Li J; Cai W; Zhu G; Gu W; Jia L; Xu B
Oncol Rep; 2013 Sep; 30(3):1355-61. PubMed ID: 23784465
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer.
Zhao L; Wang H; Li J; Liu Y; Ding Y
J Proteome Res; 2008 Sep; 7(9):3994-4003. PubMed ID: 18651761
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
8. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
[TBL] [Abstract][Full Text] [Related]
9. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
10. HOXB7 as a prognostic factor and mediator of colorectal cancer progression.
Liao WT; Jiang D; Yuan J; Cui YM; Shi XW; Chen CM; Bian XW; Deng YJ; Ding YQ
Clin Cancer Res; 2011 Jun; 17(11):3569-78. PubMed ID: 21474578
[TBL] [Abstract][Full Text] [Related]
11. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S
Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967
[TBL] [Abstract][Full Text] [Related]
12. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
13. Extrahepatic synthesis of coagulation factor VII by colorectal cancer cells promotes tumor invasion and metastasis.
Tang JQ; Fan Q; Wu WH; Jia ZC; Li H; Yang YM; Liu YC; Wan YL
Chin Med J (Engl); 2010 Dec; 123(24):3559-65. PubMed ID: 22166631
[TBL] [Abstract][Full Text] [Related]
14. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
15. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of plastin-3 via copy number gain induces the epithelial-mesenchymal transition in circulating colorectal cancer cells.
Sugimachi K; Yokobori T; Iinuma H; Ueda M; Ueo H; Shinden Y; Eguchi H; Sudo T; Suzuki A; Maehara Y; Mori M; Mimori K
Ann Surg Oncol; 2014 Oct; 21(11):3680-90. PubMed ID: 24217791
[TBL] [Abstract][Full Text] [Related]
17. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.
Wu Y; McRoberts K; Berr SS; Frierson HF; Conaway M; Theodorescu D
Oncogene; 2007 Feb; 26(5):765-73. PubMed ID: 16878152
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
[TBL] [Abstract][Full Text] [Related]
19. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
20. TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer.
Miyoshi N; Ishii H; Mimori K; Tanaka F; Hitora T; Tei M; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2010 Apr; 17(4):967-72. PubMed ID: 20033322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
